Former minor league pitcher Peter Bayer has spent his life loving the game of baseball. And now all he wants is to be welcomed back into the sport. Bayer finds himself in a frustrating situation that ...

RESEARCH TRIANGLE PARK – Drug giant Bayer is paying quite a price to acquire RTP gene therapy firm AskBio in a deal announced early today – as much as $4 billion. The upfront price is $2 billion. And ...

WHIPPANY, N.J.--(BUSINESS WIRE)--For the second consecutive year, Bayer U.S. was recognized as a Best Place to Work for Disability Inclusion, earning a score of 90 in the 2020 Disability Equality ...

Bayer Aktiengesellschaft BAYRY entered into a strategic collaboration agreement with Recursion Pharmaceuticals, Inc., a digital biology company industrializing drug discovery for the treatment of ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Bayer's latest settlement of thousands of Roundup legal ...

Bayer is the latest pharmaceutical company to join the gene therapy club, with plans to acquire Asklepios BioPharmaceutical, a private gene therapy firm based in Research Triangle Park, North Carolina ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Bayer, already facing an approaching deadline for settling ...

Bayer's recent weakness may not end anytime soon. In a nutshell, neither of these companies are positioned for rapid growth, largely because they are large and mature, and function in crowded and ...

Bayer AG settled thousands more U.S. lawsuits over its Roundup weed killer after criticism that the company was failing to uphold an $11 billion deal it announced in June to resolve the massive ...

Bayer Leverkusen sold Kai Havertz to Chelsea in September for the highest-ever fee for a German soccer player. (Photo by Friedemann Vogel/Pool via Getty Images) German soccer club Bayer 04 Leverkusen ...

Bayer Aktiengesellschaft (OTC: BAYRY) and Biogen (NASDAQ: BIIB) are both massive and multinational healthcare companies, but the case in favor of investing in each company is dramatically different.